The Newsroom
Item 1 of 3
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
Item 2 of 3
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Item 3 of 3
AdventHealth East Orlando First in Florida to Earn Advanced Foot & Ankle Surgery Certification from DNV
Recent Stories at AdventHealthMD
-
-
WFTV’s Greg Warmoth Joins AdventHealth’s Dr. Mark Socinski to Discuss His Cancer Journey — and How He Hopes His Message Will Save Others
-
Leading Health Systems Join Pioneering Effort to Improve Alzheimer’s Diagnosis
-
New State-of-the-Art Cellular Therapy Facility Opening at AdventHealth Orlando
-
The American College of Surgeons Designates AdventHealth Nicholson Center a Comprehensive Accredited Educational Institution
-
AdventHealth Palm Coast Simulation Center Serves as a Beacon of Growth and Excellence
-
AdventHealth University Inaugurates Third Leader in its History
-
Genetic Testing at AdventHealth Alerts Woman, Doctors to Aggressive Cancer Before it Develops
-
AdventHealth Clinical Research Unit Recruiting Patients with Solid Tumors Harboring MTAP Deletion for Phase I Clinical Trial